Pfizer and BionTech will deliver through the international vaccine-sharing facility COVAX some of the 2 billion COVID-19 vaccine doses it announced on Friday as new supplies for low- and middle-income countries.
The doses will be allocated “through bilateral agreements, agreements with supranational organizations as well as our partnership with COVAX,” a Pfizer spokesman said.
Get daily National news
Get daily Canada news delivered to your inbox so you'll never miss the day's top stories.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
Earlier on Friday a BioNTech spokeswoman said: “We are currently still evaluating this.”
Comments
Want to discuss? Please read our Commenting Policy first.